From: Attenuation of multiple Nef functions in HIV-1 elite controllers
Nef activity | Position on HXB2 | AAa | No. of subjectsb | Relative Nef activity (%) | p-value | q-value | ||
---|---|---|---|---|---|---|---|---|
With AA | Without AA | With AA | Without AA | |||||
HLA-I down-regulation | 8 | S | 17 | 27 | 83.6 | 97.2 | 0.01 | 0.3 |
 | 8 | R | 14 | 30 | 106.1 | 91.1 | 0.02 | 0.3 |
 | 11 | V | 20 | 21 | 87.2 | 98.9 | 0.01 | 0.3 |
 | 14 | P | 34 | 11 | 91.1 | 108 | 0.004 | 0.3 |
 | 46 | S | 36 | 8 | 96.7 | 77.1 | 0.01 | 0.3 |
 | 108 | D | 34 | 11 | 91.1 | 105.8 | 0.02 | 0.3 |
 | 108 | E | 11 | 34 | 105.8 | 91.1 | 0.02 | 0.3 |
 | 138 | C | 5 | 40 | 79.8 | 96.5 | 0.02 | 0.3 |
 | 138 | T | 40 | 5 | 96.5 | 79.8 | 0.02 | 0.3 |
 | 192 | H | 36 | 9 | 97 | 78.1 | 0.01 | 0.3 |
 | 192 | R | 6 | 39 | 84 | 96.8 | 0.04 | 0.4 |
 | 205 | N | 22 | 23 | 101 | 83.6 | 0.02 | 0.3 |
 | 205 | D | 22 | 23 | 85.9 | 98.9 | 0.03 | 0.3 |
CD74 up-regulation | 8 | S | 17 | 27 | 37.7 | 60 | 0.004 | 0.3 |
 | 28 | E | 14 | 31 | 73.7 | 42.4 | 0.008 | 0.3 |
 | 28 | D | 29 | 16 | 40.4 | 65.3 | 0.009 | 0.3 |
 | 135 | F | 10 | 35 | 35 | 57.5 | 0.003 | 0.3 |
 | 135 | Y | 34 | 11 | 57.1 | 35.1 | 0.01 | 0.3 |
CD4 down-regulation | 8 | S | 17 | 27 | 84.8 | 92.6 | 0.007 | 0.3 |
 | 14 | P | 34 | 11 | 86.1 | 97.9 | 0.003 | 0.1 |
 | 14 | S | 5 | 40 | 102.9 | 87.2 | 0.02 | 0.4 |
 | 15 | A | 11 | 34 | 76.9 | 91.3 | 0.02 | 0.4 |
 | 21 | K | 11 | 34 | 70.7 | 91.6 | 0.002 | 0.1 |
 | 21 | R | 28 | 17 | 91.6 | 76.9 | 0.02 | 0.4 |
 | 105 | R | 12 | 33 | 76.6 | 91.9 | 0.003 | 0.1 |
 | 163 | C | 9 | 36 | 98.1 | 86.6 | 0.02 | 0.4 |